Literature DB >> 7531708

Phosphopeptide mapping of cholecystokinin receptors on agonist-stimulated native pancreatic acinar cells.

F Ozcelebi1, L J Miller.   

Abstract

The cholecystokinin (CCK) receptor on the rat pancreatic acinar cell is a G protein-coupled receptor that is phosphorylated in response to homologous and heterologous agonist stimulation. In this work we have studied the stoichiometry of receptor phosphorylation and have utilized one-dimensional phosphopeptide mapping after cyanogen bromide cleavage to demonstrate that the third intracellular loop is the predominant domain of phosphorylation of this receptor in response to these treatments. Of the average 5 mol of phosphate/mol of receptor, greater than 95% was on the third loop, with the remainder residing on the carboxyl-terminal tail. Serine residues were the site of greater than 95% of phosphorylation, with threonine representing the remainder, and no phosphotyrosine was detected. Further, we have utilized two-dimensional phosphopeptide mapping after subtilisin cleavage to identify differing sites of CCK receptor phosphorylation which are dependent on the agonist utilized to stimulate this cell. Both qualitative and quantitative differences in phosphorylation sites were observed after acinar cell stimulation with different protein kinase C agonists. Further, distinct phosphopeptides on the map were identified as representing substrate(s) of a staurosporine-insensitive kinase activity stimulated only by receptor occupation with native CCK and were felt to represent site(s) of action of a member of the G protein-coupled receptor kinase family. This represents a sensitive and powerful approach that is applicable to sparse receptors residing in their native cellular environment to assess possible differences in patterns of phosphorylation which may be important in agonist-specific receptor regulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531708     DOI: 10.1074/jbc.270.7.3435

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  G-protein-coupled receptor phosphorylation: where, when and by whom.

Authors:  A B Tobin
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

Review 2.  Regulatory mechanisms that modulate signalling by G-protein-coupled receptors.

Authors:  S K Böhm; E F Grady; N W Bunnett
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

3.  Ligand-induced internalization of the type 1 cholecystokinin receptor independent of recognized signaling activity.

Authors:  Erin E Cawston; Kaleeckal G Harikumar; Laurence J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-02       Impact factor: 4.249

4.  Serotonin and cholecystokinin synergistically stimulate rat vagal primary afferent neurones.

Authors:  Y Li; X Y Wu; C Owyang
Journal:  J Physiol       Date:  2004-07-02       Impact factor: 5.182

Review 5.  Structural basis of cholecystokinin receptor binding and regulation.

Authors:  Laurence J Miller; Fan Gao
Journal:  Pharmacol Ther       Date:  2008-05-11       Impact factor: 12.310

6.  Ligand-induced internalization of cholecystokinin receptors. Demonstration of the importance of the carboxyl terminus for ligand-induced internalization of the rat cholecystokinin type B receptor but not the type A receptor.

Authors:  M Pohl; S Silvente-Poirot; J R Pisegna; N I Tarasova; S A Wank
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

7.  Dual pathways of internalization of the cholecystokinin receptor.

Authors:  B F Roettger; R U Rentsch; D Pinon; E Holicky; E Hadac; J M Larkin; L J Miller
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

8.  Insulation of a G protein-coupled receptor on the plasmalemmal surface of the pancreatic acinar cell.

Authors:  B F Roettger; R U Rentsch; E M Hadac; E H Hellen; T P Burghardt; L J Miller
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.